Opinion|Videos|October 24, 2024
Clinical Presentation and Risk Factors
Author(s)Toby Maher, MD, PhD
Key Takeaways
- IPF diagnosis relies on clinical evaluation, HRCT, and occasionally lung biopsy to identify usual interstitial pneumonia patterns.
- The average time to IPF diagnosis can be delayed up to two years due to symptom overlap with other conditions.
Toby Maher, MD, PhD, discusses how common signs and symptoms of idiopathic pulmonary fibrosis (IPF) at diagnosis can indicate disease progression, while also identifying key risk factors associated with IPF and emphasizing the importance of modifying certain lifestyle factors to help prevent the disease.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What signs and symptoms of IPF are often present at diagnosis, and what patient characteristics at the time of diagnosis may be predictive of disease progression?
- What risk factors are associated with IPF, and what changes can be made to modifiable risk factors to prevent the disease?
Advertisement
Related to this article
Sphingolipid profiles in plasma and breath condensate differed between IPF and f-HP and tracked with disease severity, CHEST 2026 data show.
From taladegib to admilparant and inhaled treprostinil, here are the key 2026 advances in idiopathic pulmonary fibrosis care.
Pharmacists outline new oncologic therapeutics, from pancreatic cancer to myeloma, and what high prices and crowded markets mean for payers.
Invivyd presented preclinical IDWeek 2026 data on VMS063, an investigational antibody that neutralized B3 and D8 measles variants in vitro.
The FDA granted accelerated approval to the first plasmid DNA-based immunotherapy for adults with recurrent respiratory papillomatosis (RRP).
October's FDA approvals included the introduction of 5 non-oncology treatment options across specialties.
A phase 4 study found 69% of patients with OAB were consistently satisfied with vibegron at 12 months, with exploratory persistence of 59.8%.
Initial frontal fibrosing alopecia treatment was largely similar in Black and White patients, though tetracycline use was higher in Black patients.
Advertisement
Advertisement
Trending on AJMC
1
Occasional Cannabis Use Linked to 40% Higher Odds of Stroke
2
Enlicitide LDL-C Lowering Holds Across Risk Levels Up to 2 Years
3
GLP-1 Use Tied to Lower Diabetes, CV Risk vs Metformin in Prediabetes
4
Invivyd Unveils Measles Antibody Candidate VMS063 at IDWeek 2026
5